Use of arginase inhibitors in the treatment of asthma and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/69 (2006.01) A61K 31/198 (2006.01) A61P 11/06 (2006.01) A61P 37/08 (2006.01)

Patent

CA 2669300

The present invention relates to the use of an arginase inhibitor for the preparation of a medicament for the prophylactic maintenance therapy of an asthmatic or allergic patient by preventing obstruction of upper and lower airways, in particular allergen-induced bronchial obstruction and/or airway hyperresponsiveness. The patients are either asthmatic or have allergic rhinitis. Preferably, the arginase inhibitor is 2 (S) -amino-6-boronohexanoic acid (ABH).

La présente invention porte sur l'utilisation d'un inhibiteur de l'arginase pour la préparation d'un médicament pour la thérapie d'entretien prophylactique d'un patient asthmatique ou allergique par la prévention de l'obstruction des voies respiratoires supérieures et inférieures, en particulier l'obstruction des bronches induite par un allergène et/ou une hypersensibilité des voies respiratoires. Les patients soit sont asthmatiques, soit ont une rhinite allergique. De préférence, l'inhibiteur de l'arginase est l'acide 2(S)-amino-6-boronohexanoïque (ABH).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of arginase inhibitors in the treatment of asthma and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of arginase inhibitors in the treatment of asthma and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of arginase inhibitors in the treatment of asthma and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1622163

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.